Logicbio therapeutics, inc. (LOGC)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-41,886

-40,128

-35,724

-29,475

-23,014

-17,621

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense

355

289

229

154

119

89

0

0

0

Net amortization of premiums and discounts on investments

315

436

0

0

0

-

-

-

-

Stock-based compensation expense

2,336

1,807

1,913

1,678

1,292

1,104

0

0

0

Non-cash interest expense

0

-

-

-

-

-

-

-

-

Non-cash lease expense

1,199

1,168

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

1,272

777

-104

457

698

150

0

0

0

Other assets

-

-

-

-134

-193

-249

0

0

0

Accounts payable

829

-527

1,384

756

906

35

0

0

0

Accrued expenses and other current liabilities

-577

-247

-160

927

538

887

0

0

0

Deferred revenue

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-38,056

-38,750

-31,688

-25,913

-20,345

-15,267

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of investments

-

58,490

0

0

0

-

-

-

-

Maturities of investments

0

-

-

-

-

-

-

-

-

Purchase of property and equipment

-

1,415

1,336

1,348

858

614

0

0

0

Net cash provided by (used in) investing activities

43,804

-18,505

-25,426

-39,141

-45,385

-579

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of stock options

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

0

-

-

-

-

-

-

-

0

Effect on foreign exchange rates on cash and cash equivalents

-

9

5

7

15

17

0

0

0

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

15,905

-47,177

25,949

7,341

6,591

56,477

0

0

0

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest

0

-

-

-

-

-

-

-

-

Cash paid for income taxes

-

6

70

84

93

164

0

0

0

Right-of-use assets obtained in exchange for operating lease obligation

-

1,461

0

0

0

-

-

-

-

Property and equipment purchases in accounts payable and accrued expenses

-

-

0

0

0

-

-

-

0